Phase 2/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX/COVID-12 vaccine

Journal:

Science Advances

Published:

2025-06-27

DOI:

10.1126/sciadv.adq2887

Affiliations:

31

Authors:

39

Go to article

Institutions	Authors	Share
National Institute of Respiratory Diseases-Mexico (INER), Mexico	8.000000	0.21
Laboratorio Avi Mex S.A. de C.V. (Avimex), Mexico	8.000000	0.21
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	3.750000	0.10
XXI Century National Medical Center, IMSS, Mexico	3.000000	0.08
OSMO / Red OSMO Oaxaca, Mexico	2.000000	0.05
iLS Clinical Research, Mexico	1.000000	0.03
National Institute of Medical Science and Nutrition Salvador Zubiran (INCMNSZ), Mexico	1.000000	0.03
CAIMED Mexico Medical Care and Research Center (CAIMED Mexico), Mexico	1.000000	0.03
Centro de Investigación Clínica Acelerada (CICA), Mexico	1.000000	0.03
Clinical Research Institute (CRI), Mexico	1.000000	0.03
Centro de Investigación Clínica Chapultepec (CICC), Mexico	1.000000	0.03
Unidad de Atención Médica e Investigación en Salud (UNAMIS), Mexico	1.000000	0.03
Autonomous University of Yucatán (UADY), Mexico	1.000000	0.03
Centro Multidisciplinario para el Desarrollo Especializado de la Investigación Clínica en Yucatán (CEMDEICY), Mexico	1.000000	0.03
Centro de Investigación Clínica del Pacifico (CICPA), Mexico	1.000000	0.03
Instituto Veracruzano de Investigación Clínica (IVIC), Mexico	1.000000	0.03
Hospital Cardiológica Aguascalientes, Mexico	1.000000	0.03
Consultora Mextrategy, Mexico	1.000000	0.03
Consejo Nacional de Humanidades Ciencias y Tecnologías (CONAHCYT), Mexico	0.500000	0.01
National Polytechnic Institute (IPN), Mexico	0.500000	0.01
Medical University of Vienna (MUW), Austria	0.250000	0.01

Interested in Immunology?